184 related articles for article (PubMed ID: 36093518)
1. Histone methyltransferase KMT2D mediated lipid metabolism via peroxisome proliferator-activated receptor gamma in prostate cancer.
Zhai Q; Luo M; Zhang Y; Zhang W; Wu C; Lv S; Wei Q
Transl Cancer Res; 2022 Aug; 11(8):2607-2621. PubMed ID: 36093518
[TBL] [Abstract][Full Text] [Related]
2. Histone methyltransferase KMT2D promotes prostate cancer progression through paracrine IL-6 signaling.
Zhang J; Ye Y; Xu Z; Luo M; Wu C; Zhang Y; Lv S; Wei Q
Biochem Biophys Res Commun; 2023 May; 655():35-43. PubMed ID: 36924677
[TBL] [Abstract][Full Text] [Related]
3. Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma.
Tsukahara T; Tsukahara R; Yasuda S; Makarova N; Valentine WJ; Allison P; Yuan H; Baker DL; Li Z; Bittman R; Parrill A; Tigyi G
J Biol Chem; 2006 Feb; 281(6):3398-407. PubMed ID: 16321982
[TBL] [Abstract][Full Text] [Related]
4. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome Proliferator-Activated Receptor
Hao K; Wang J; Yu H; Chen L; Zeng W; Wang Z; Hu G
PPAR Res; 2023; 2023():6422804. PubMed ID: 38020065
[TBL] [Abstract][Full Text] [Related]
6. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
[TBL] [Abstract][Full Text] [Related]
7. Loss of KMT2D induces prostate cancer ROS-mediated DNA damage by suppressing the enhancer activity and DNA binding of antioxidant transcription factor FOXO3.
Lv S; Wen H; Shan X; Li J; Wu Y; Yu X; Huang W; Wei Q
Epigenetics; 2019 Dec; 14(12):1194-1208. PubMed ID: 31232159
[TBL] [Abstract][Full Text] [Related]
8. The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer.
Chu R; van Hasselt A; Vlantis AC; Ng EK; Liu SY; Fan MD; Ng SK; Chan AB; Liu Z; Li XY; Chen GG
Cancer; 2014 Jan; 120(1):142-53. PubMed ID: 24114184
[TBL] [Abstract][Full Text] [Related]
9. Free Fatty Acids Promote the Development of Prostate Cancer by Upregulating Peroxisome Proliferator-Activated Receptor Gamma.
Ha X; Wang J; Chen K; Deng Y; Zhang X; Feng J; Li X; Zhu J; Ma Y; Qiu T; Wang C; Xie J; Zhang J
Cancer Manag Res; 2020; 12():1355-1369. PubMed ID: 32158268
[TBL] [Abstract][Full Text] [Related]
10. KMT2D deficiency enhances the anti-cancer activity of L48H37 in pancreatic ductal adenocarcinoma.
Li SS; Jiang WL; Xiao WQ; Li K; Zhang YF; Guo XY; Dai YQ; Zhao QY; Jiang MJ; Lu ZJ; Wan R
World J Gastrointest Oncol; 2019 Aug; 11(8):599-621. PubMed ID: 31435462
[TBL] [Abstract][Full Text] [Related]
11. Down-regulated peroxisome proliferator-activated receptor γ (PPARγ) in lung epithelial cells promotes a PPARγ agonist-reversible proinflammatory phenotype in chronic obstructive pulmonary disease (COPD).
Lakshmi SP; Reddy AT; Zhang Y; Sciurba FC; Mallampalli RK; Duncan SR; Reddy RC
J Biol Chem; 2014 Mar; 289(10):6383-6393. PubMed ID: 24368768
[TBL] [Abstract][Full Text] [Related]
12. Small molecule inhibitors of the prostate cancer target KMT2D.
Yu Q; Liao Z; Liu D; Xie W; Liu Z; Liao G; Wang C
Biochem Biophys Res Commun; 2020 Dec; 533(3):540-547. PubMed ID: 32988590
[TBL] [Abstract][Full Text] [Related]
13. KMT2D deficiency disturbs the proliferation and cell cycle activity of dental epithelial cell line (LS8) partially via Wnt signaling.
Pang L; Tian H; Gao X; Wang W; Wang X; Zhang Z
Biosci Rep; 2021 Nov; 41(11):. PubMed ID: 34724040
[TBL] [Abstract][Full Text] [Related]
14. Cancer-preventive rexinoid modulates neutral lipid contents of mammary epithelial cells through a peroxisome proliferator-activated receptor γ-dependent mechanism.
Uray IP; Rodenberg JM; Bissonnette RP; Brown PH; Mancini MA
Mol Pharmacol; 2012 Feb; 81(2):228-38. PubMed ID: 22053058
[TBL] [Abstract][Full Text] [Related]
15. [Effect of telmisartan on peroxisome proliferator-activated receptor γ signaling pathway in 3T3-L1 adipocytes].
Fang T; Cui XX; Shen N; Li YH; Xi PQ; Zhang Y; Xie Y; Li GW; Tian FS
Zhonghua Yi Xue Za Zhi; 2018 Jul; 98(26):2104-2109. PubMed ID: 30032509
[No Abstract] [Full Text] [Related]
16. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment.
Fu M; Rao M; Bouras T; Wang C; Wu K; Zhang X; Li Z; Yao TP; Pestell RG
J Biol Chem; 2005 Apr; 280(17):16934-41. PubMed ID: 15713663
[TBL] [Abstract][Full Text] [Related]
17. MRNA expression of genes regulating lipid metabolism in ringed seals (Pusa hispida) from differently polluted areas.
Castelli MG; Rusten M; Goksøyr A; Routti H
Aquat Toxicol; 2014 Jan; 146():239-46. PubMed ID: 24334006
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
19. Thiazolidinediones/PPARγ agonists and fatty acid synthase inhibitors as an experimental combination therapy for prostate cancer.
Mansour M; Schwartz D; Judd R; Akingbemi B; Braden T; Morrison E; Dennis J; Bartol F; Hazi A; Napier I; Abdel-Mageed AB
Int J Oncol; 2011 Feb; 38(2):537-46. PubMed ID: 21170507
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma controls prostate cancer cell growth through AR-dependent and independent mechanisms.
Elix CC; Salgia MM; Otto-Duessel M; Copeland BT; Yoo C; Lee M; Tew BY; Ann D; Pal SK; Jones JO
Prostate; 2020 Feb; 80(2):162-172. PubMed ID: 31769890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
